Plasma-derived Medical Product Market, Global Outlook and Forecast 2022-2028

February 2022 | 108 pages | ID: PC4F1A959701EN
Market Monitor Global

Abstracts

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation

This report contains market size and forecasts of Plasma-derived Medical Product in Global, including the following market information:

Global Plasma-derived Medical Product Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Plasma-derived Medical Product market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immune Globulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Plasma-derived Medical Product include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasma-derived Medical Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Plasma-derived Medical Product Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Plasma-derived Medical Product Market Segment Percentages, by Type, 2021 (%)

• Immune Globulin
• Coagulation Factor
• Albumin
• Other

Global Plasma-derived Medical Product Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Plasma-derived Medical Product Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacy
• Other

Global Plasma-derived Medical Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Plasma-derived Medical Product Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Plasma-derived Medical Product revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Plasma-derived Medical Product revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda
• CSL
• Grifols
• Octapharma
• Kedrion
• LFB Group
• Biotest
• BPL
• RAAS
• CBPO
• Hualan Bio
• Tiantan Bio
• Shuanglin Bio
• Boya Bio
• Yuanda Shuyang
• Weiguang Bio
• Nanyue Bio
• KM Biologics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Plasma-derived Medical Product Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Plasma-derived Medical Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PLASMA-DERIVED MEDICAL PRODUCT OVERALL MARKET SIZE

2.1 Global Plasma-derived Medical Product Market Size: 2021 VS 2028
2.2 Global Plasma-derived Medical Product Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Plasma-derived Medical Product Players in Global Market
3.2 Top Global Plasma-derived Medical Product Companies Ranked by Revenue
3.3 Global Plasma-derived Medical Product Revenue by Companies
3.4 Top 3 and Top 5 Plasma-derived Medical Product Companies in Global Market, by Revenue in 2021
3.5 Global Companies Plasma-derived Medical Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasma-derived Medical Product Players in Global Market
  3.6.1 List of Global Tier 1 Plasma-derived Medical Product Companies
  3.6.2 List of Global Tier 2 and Tier 3 Plasma-derived Medical Product Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Plasma-derived Medical Product Market Size Markets, 2021 & 2028
  4.1.2 Immune Globulin
  4.1.3 Coagulation Factor
  4.1.4 Albumin
  4.1.5 Other
4.2 By Type - Global Plasma-derived Medical Product Revenue & Forecasts
  4.2.1 By Type - Global Plasma-derived Medical Product Revenue, 2017-2022
  4.2.2 By Type - Global Plasma-derived Medical Product Revenue, 2023-2028
  4.2.3 By Type - Global Plasma-derived Medical Product Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Plasma-derived Medical Product Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Retail Pharmacy
  5.1.4 Other
5.2 By Application - Global Plasma-derived Medical Product Revenue & Forecasts
  5.2.1 By Application - Global Plasma-derived Medical Product Revenue, 2017-2022
  5.2.2 By Application - Global Plasma-derived Medical Product Revenue, 2023-2028
  5.2.3 By Application - Global Plasma-derived Medical Product Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Plasma-derived Medical Product Market Size, 2021 & 2028
6.2 By Region - Global Plasma-derived Medical Product Revenue & Forecasts
  6.2.1 By Region - Global Plasma-derived Medical Product Revenue, 2017-2022
  6.2.2 By Region - Global Plasma-derived Medical Product Revenue, 2023-2028
  6.2.3 By Region - Global Plasma-derived Medical Product Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Plasma-derived Medical Product Revenue, 2017-2028
  6.3.2 US Plasma-derived Medical Product Market Size, 2017-2028
  6.3.3 Canada Plasma-derived Medical Product Market Size, 2017-2028
  6.3.4 Mexico Plasma-derived Medical Product Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Plasma-derived Medical Product Revenue, 2017-2028
  6.4.2 Germany Plasma-derived Medical Product Market Size, 2017-2028
  6.4.3 France Plasma-derived Medical Product Market Size, 2017-2028
  6.4.4 U.K. Plasma-derived Medical Product Market Size, 2017-2028
  6.4.5 Italy Plasma-derived Medical Product Market Size, 2017-2028
  6.4.6 Russia Plasma-derived Medical Product Market Size, 2017-2028
  6.4.7 Nordic Countries Plasma-derived Medical Product Market Size, 2017-2028
  6.4.8 Benelux Plasma-derived Medical Product Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Plasma-derived Medical Product Revenue, 2017-2028
  6.5.2 China Plasma-derived Medical Product Market Size, 2017-2028
  6.5.3 Japan Plasma-derived Medical Product Market Size, 2017-2028
  6.5.4 South Korea Plasma-derived Medical Product Market Size, 2017-2028
  6.5.5 Southeast Asia Plasma-derived Medical Product Market Size, 2017-2028
  6.5.6 India Plasma-derived Medical Product Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Plasma-derived Medical Product Revenue, 2017-2028
  6.6.2 Brazil Plasma-derived Medical Product Market Size, 2017-2028
  6.6.3 Argentina Plasma-derived Medical Product Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Plasma-derived Medical Product Revenue, 2017-2028
  6.7.2 Turkey Plasma-derived Medical Product Market Size, 2017-2028
  6.7.3 Israel Plasma-derived Medical Product Market Size, 2017-2028
  6.7.4 Saudi Arabia Plasma-derived Medical Product Market Size, 2017-2028
  6.7.5 UAE Plasma-derived Medical Product Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda
  7.1.1 Takeda Corporate Summary
  7.1.2 Takeda Business Overview
  7.1.3 Takeda Plasma-derived Medical Product Major Product Offerings
  7.1.4 Takeda Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.1.5 Takeda Key News
7.2 CSL
  7.2.1 CSL Corporate Summary
  7.2.2 CSL Business Overview
  7.2.3 CSL Plasma-derived Medical Product Major Product Offerings
  7.2.4 CSL Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.2.5 CSL Key News
7.3 Grifols
  7.3.1 Grifols Corporate Summary
  7.3.2 Grifols Business Overview
  7.3.3 Grifols Plasma-derived Medical Product Major Product Offerings
  7.3.4 Grifols Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.3.5 Grifols Key News
7.4 Octapharma
  7.4.1 Octapharma Corporate Summary
  7.4.2 Octapharma Business Overview
  7.4.3 Octapharma Plasma-derived Medical Product Major Product Offerings
  7.4.4 Octapharma Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.4.5 Octapharma Key News
7.5 Kedrion
  7.5.1 Kedrion Corporate Summary
  7.5.2 Kedrion Business Overview
  7.5.3 Kedrion Plasma-derived Medical Product Major Product Offerings
  7.5.4 Kedrion Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.5.5 Kedrion Key News
7.6 LFB Group
  7.6.1 LFB Group Corporate Summary
  7.6.2 LFB Group Business Overview
  7.6.3 LFB Group Plasma-derived Medical Product Major Product Offerings
  7.6.4 LFB Group Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.6.5 LFB Group Key News
7.7 Biotest
  7.7.1 Biotest Corporate Summary
  7.7.2 Biotest Business Overview
  7.7.3 Biotest Plasma-derived Medical Product Major Product Offerings
  7.7.4 Biotest Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.7.5 Biotest Key News
7.8 BPL
  7.8.1 BPL Corporate Summary
  7.8.2 BPL Business Overview
  7.8.3 BPL Plasma-derived Medical Product Major Product Offerings
  7.8.4 BPL Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.8.5 BPL Key News
7.9 RAAS
  7.9.1 RAAS Corporate Summary
  7.9.2 RAAS Business Overview
  7.9.3 RAAS Plasma-derived Medical Product Major Product Offerings
  7.9.4 RAAS Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.9.5 RAAS Key News
7.10 CBPO
  7.10.1 CBPO Corporate Summary
  7.10.2 CBPO Business Overview
  7.10.3 CBPO Plasma-derived Medical Product Major Product Offerings
  7.10.4 CBPO Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.10.5 CBPO Key News
7.11 Hualan Bio
  7.11.1 Hualan Bio Corporate Summary
  7.11.2 Hualan Bio Business Overview
  7.11.3 Hualan Bio Plasma-derived Medical Product Major Product Offerings
  7.11.4 Hualan Bio Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.11.5 Hualan Bio Key News
7.12 Tiantan Bio
  7.12.1 Tiantan Bio Corporate Summary
  7.12.2 Tiantan Bio Business Overview
  7.12.3 Tiantan Bio Plasma-derived Medical Product Major Product Offerings
  7.12.4 Tiantan Bio Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.12.5 Tiantan Bio Key News
7.13 Shuanglin Bio
  7.13.1 Shuanglin Bio Corporate Summary
  7.13.2 Shuanglin Bio Business Overview
  7.13.3 Shuanglin Bio Plasma-derived Medical Product Major Product Offerings
  7.13.4 Shuanglin Bio Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.13.5 Shuanglin Bio Key News
7.14 Boya Bio
  7.14.1 Boya Bio Corporate Summary
  7.14.2 Boya Bio Business Overview
  7.14.3 Boya Bio Plasma-derived Medical Product Major Product Offerings
  7.14.4 Boya Bio Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.14.5 Boya Bio Key News
7.15 Yuanda Shuyang
  7.15.1 Yuanda Shuyang Corporate Summary
  7.15.2 Yuanda Shuyang Business Overview
  7.15.3 Yuanda Shuyang Plasma-derived Medical Product Major Product Offerings
  7.15.4 Yuanda Shuyang Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.15.5 Yuanda Shuyang Key News
7.16 Weiguang Bio
  7.16.1 Weiguang Bio Corporate Summary
  7.16.2 Weiguang Bio Business Overview
  7.16.3 Weiguang Bio Plasma-derived Medical Product Major Product Offerings
  7.16.4 Weiguang Bio Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.16.5 Weiguang Bio Key News
7.17 Nanyue Bio
  7.17.1 Nanyue Bio Corporate Summary
  7.17.2 Nanyue Bio Business Overview
  7.17.3 Nanyue Bio Plasma-derived Medical Product Major Product Offerings
  7.17.4 Nanyue Bio Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.17.5 Nanyue Bio Key News
7.18 KM Biologics
  7.18.1 KM Biologics Corporate Summary
  7.18.2 KM Biologics Business Overview
  7.18.3 KM Biologics Plasma-derived Medical Product Major Product Offerings
  7.18.4 KM Biologics Plasma-derived Medical Product Revenue in Global Market (2017-2022)
  7.18.5 KM Biologics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Plasma-derived Medical Product Market Opportunities & Trends in Global Market
Table 2. Plasma-derived Medical Product Market Drivers in Global Market
Table 3. Plasma-derived Medical Product Market Restraints in Global Market
Table 4. Key Players of Plasma-derived Medical Product in Global Market
Table 5. Top Plasma-derived Medical Product Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Plasma-derived Medical Product Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Plasma-derived Medical Product Revenue Share by Companies, 2017-2022
Table 8. Global Companies Plasma-derived Medical Product Product Type
Table 9. List of Global Tier 1 Plasma-derived Medical Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Plasma-derived Medical Product Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Plasma-derived Medical Product Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Plasma-derived Medical Product Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Plasma-derived Medical Product Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Plasma-derived Medical Product Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Plasma-derived Medical Product Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Plasma-derived Medical Product Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Plasma-derived Medical Product Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Plasma-derived Medical Product Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Plasma-derived Medical Product Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Plasma-derived Medical Product Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Plasma-derived Medical Product Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Plasma-derived Medical Product Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Plasma-derived Medical Product Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Plasma-derived Medical Product Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda Plasma-derived Medical Product Product Offerings
Table 32. Takeda Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 33. CSL Corporate Summary
Table 34. CSL Plasma-derived Medical Product Product Offerings
Table 35. CSL Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 36. Grifols Corporate Summary
Table 37. Grifols Plasma-derived Medical Product Product Offerings
Table 38. Grifols Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 39. Octapharma Corporate Summary
Table 40. Octapharma Plasma-derived Medical Product Product Offerings
Table 41. Octapharma Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 42. Kedrion Corporate Summary
Table 43. Kedrion Plasma-derived Medical Product Product Offerings
Table 44. Kedrion Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 45. LFB Group Corporate Summary
Table 46. LFB Group Plasma-derived Medical Product Product Offerings
Table 47. LFB Group Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 48. Biotest Corporate Summary
Table 49. Biotest Plasma-derived Medical Product Product Offerings
Table 50. Biotest Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 51. BPL Corporate Summary
Table 52. BPL Plasma-derived Medical Product Product Offerings
Table 53. BPL Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 54. RAAS Corporate Summary
Table 55. RAAS Plasma-derived Medical Product Product Offerings
Table 56. RAAS Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 57. CBPO Corporate Summary
Table 58. CBPO Plasma-derived Medical Product Product Offerings
Table 59. CBPO Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 60. Hualan Bio Corporate Summary
Table 61. Hualan Bio Plasma-derived Medical Product Product Offerings
Table 62. Hualan Bio Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 63. Tiantan Bio Corporate Summary
Table 64. Tiantan Bio Plasma-derived Medical Product Product Offerings
Table 65. Tiantan Bio Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 66. Shuanglin Bio Corporate Summary
Table 67. Shuanglin Bio Plasma-derived Medical Product Product Offerings
Table 68. Shuanglin Bio Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 69. Boya Bio Corporate Summary
Table 70. Boya Bio Plasma-derived Medical Product Product Offerings
Table 71. Boya Bio Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 72. Yuanda Shuyang Corporate Summary
Table 73. Yuanda Shuyang Plasma-derived Medical Product Product Offerings
Table 74. Yuanda Shuyang Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 75. Weiguang Bio Corporate Summary
Table 76. Weiguang Bio Plasma-derived Medical Product Product Offerings
Table 77. Weiguang Bio Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 78. Nanyue Bio Corporate Summary
Table 79. Nanyue Bio Plasma-derived Medical Product Product Offerings
Table 80. Nanyue Bio Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)
Table 81. KM Biologics Corporate Summary
Table 82. KM Biologics Plasma-derived Medical Product Product Offerings
Table 83. KM Biologics Plasma-derived Medical Product Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Plasma-derived Medical Product Segment by Type in 2021
Figure 2. Plasma-derived Medical Product Segment by Application in 2021
Figure 3. Global Plasma-derived Medical Product Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Plasma-derived Medical Product Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Plasma-derived Medical Product Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plasma-derived Medical Product Revenue in 2021
Figure 8. By Type - Global Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 9. By Application - Global Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 10. By Region - Global Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 11. By Country - North America Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 12. US Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 16. Germany Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 17. France Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 24. China Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 28. India Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 30. Brazil Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Plasma-derived Medical Product Revenue Market Share, 2017-2028
Figure 33. Turkey Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Plasma-derived Medical Product Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CSL Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Grifols Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Octapharma Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kedrion Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. LFB Group Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biotest Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BPL Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. RAAS Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CBPO Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Hualan Bio Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Tiantan Bio Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Shuanglin Bio Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Boya Bio Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Yuanda Shuyang Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Weiguang Bio Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Nanyue Bio Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. KM Biologics Plasma-derived Medical Product Revenue Year Over Year Growth (US$, Mn) & (2017-2022)